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Abstract:  Photodynamic  treatment  (PDT)  elicits  a  diverse  range  of  cellular  responses, 
including apoptosis. Previously, we showed that PDT stimulates caspase-3 activity, and 
subsequent cleavage and activation of p21-activated kinase 2 (PAK2) in human epidermal 
carcinoma A431 cells. In the current study, pretreatment with nitric oxide (NO) scavengers 
inhibited PDT-induced mitochondrial membrane potential (MMP) changes, activation of 
caspase-9, caspase-3, p21-activated protein kinase 2 (PAK2) and c-Jun N-terminal kinase 
(JNK), and gene expression of p53 and p21 involved in apoptotic signaling. Moreover, 
PAK2 activity was required for PDT-induced JNK activation and apoptosis. Inhibition of 
p53  mRNA  expression  using  small  interfering  RNA  (siRNA)  additionally  blocked 
activation of PAK2 and apoptosis induced by PDT. Importantly, our data also show that 
PDT triggers cell death via inactivation of ERK-mediated anti-apoptotic pathway. PDT 
triggers cell death via inactivation of the HSP90/multi-chaperone complex and subsequent 
degradation  of  Ras,  further  inhibiting  anti-apoptotic  processes,  such  as  the  Ras→ERK 
signal transduction pathway. Furthermore, we did not observe two-stage JNK activation for 
regulation of PAK2 activity in the PDT-induced apoptotic pathway in HUVECs, which 
was reported earlier in A431 cells. Based on the collective results, we have proposed a 
model for the PDT-triggered inactivation of the survival signal and apoptotic signaling 
cascade with Rose Bengal (RB), which sequentially involves singlet oxygen, Ca
2+, NO, 
p53, caspase-9, caspase-3, PAK2, and JNK. 
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1. Introduction 
Photodynamic treatment (PDT) of cells involves the selective delivery of a photosensitive dye into 
target  cells,  followed  by  visible  light  irradiation.  Interaction  of  the  excited  photosensitizer  with 
molecular oxygen results in the formation of reactive oxygen species (ROS), such as singlet oxygen 
(
1O2)  and  hydroxyl  radicals,  which  damage  cellular  constituents  and  are  possibly  responsible  for 
triggering  cell  destruction  [1,2].  Photosensitizers  include  dyes,  such  as  Rose  Bengal  (RB)  and 
methylene  blue  (MB),  drugs  such  as  tetracyclines  and  chlorpromazine,  and  endogenous 
porphyrins [3,4]. Recently, PDT has been applied to treat solid malignancies, non-malignant tumors 
and lung cancer [5,6]. PDT induces a diverse range of cellular responses, including apoptosis [7], 
which  plays  an  important  role  in  embryogenesis  and  homeostasis  of  multicellular  organisms. 
Impairment of apoptosis may cause several human diseases, including neurodegenerative disorders and 
cancer [8]. We previously showed that PDT triggers apoptosis through multiple biochemical changes, 
including singlet oxygen generation as well as activation of JNK, caspase-3, and PAK2 [9,10]. These 
effects were blocked by the antioxidants L-histidine and curcumin, suggesting that ROS play important 
roles in PDT-induced apoptosis [9,10].  
Nitric oxide (NO) is an important second messenger involved in a variety of cellular responses and 
biological functions, including tumor development, metastasis and apoptosis [11–13]. NO is largely 
produced  in  mitochondria  through  the  actions  of  a  Ca
2+-sensitive  mitochondrial  NO  synthase 
(NOS) [14,15]. This NOS-mediated NO production controls oxygen consumption and mitochondrial 
membrane potential through cytochrome c oxidase; the NO molecule is subsequently reactivated with 
superoxide to produce peroxynitrite, which further modifies its target substrates and induces oxidative 
stress  [16–18].  Recent  studies  have  shown  that  oxidative  stress  and  Ca
2+  influx  act  as  upstream 
regulators of mitochondrial NOS activity [19,20].  
Protein phosphorylation appears to be involved in the regulation of apoptosis. Changes in protein 
kinase  activity  observed  during  apoptosis  in  a  variety  of  cell  types  [21]  signify  a  role  of 
phosphorylation  in  apoptosis  control.  In  particular,  c-Jun  N-terminal  kinase  (JNK)  acts  as  a  key 
component  in  regulating  entry  into  apoptosis  in  several  cell  types  [22–24].  In  addition  to  JNK,  
p21-activated kinase (PAK) may be involved in cell death signaling events during apoptosis [9,25–28]. 
Although  the  direct  downstream  substrates  of  PAKs  are  largely  unknown,  earlier  studies  have 
established that these proteins act as upstream regulators of the JNK and p38 MAPK pathways [29,30]. 
Furthermore, we previously reported that PAK2 activation is required for photodynamic treatment 
(PDT)-induced  apoptosis  of  A431  cells  [9].  However,  despite  accumulating  evidence  on  the 
importance of PAK2 in apoptotic signaling, its direct downstream substrates and precise regulatory 
mechanisms remain to be elucidated.  
HSP90, a 90 kDa isoform of the heat shock protein (HSP) family proteins, acts in concert with other 
chaperones and partners to facilitate the maturation and folding of client proteins via formation of a  
HSP90/multi-chaperone  complex  [31]. Two HSP90 client  proteins,  Raf-1 and MAPK/ERK kinase 
(MEK), are components of the Ras/extracellular signal regulated kinase (ERK)-dependent pathway 
that  is  involved  in  both  proliferation  and  anti-apoptosis  [32].  However,  there  are  no  documented 
reports on the effects of PDT on ERK-mediated survival signaling in HUVECs. Int. J. Mol. Sci. 2011, 12                       
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Earlier studies by our group have shown that PDT activates caspase-3 and subsequent p21-activated 
kinase 2 (PAK2) cleavage/activation and DNA fragmentation [9,10]. In this study, we have focused on 
clarifying the precise regulatory mechanisms of PDT-induced apoptosis in HUVECs. 
2. Results and Discussion 
Singlet oxygen is  an important  cellular mediator for PDT-induced responses  [33–35]. We have 
already  demonstrated  that  singlet  oxygen  mediates  the  PDT-induced  activation  of  caspase-3  and 
subsequent apoptotic biochemical changes in A431 cells [9,10]. However, the cytotoxic effects of PDT 
on HUVECs have not been established to date. Experiments in the current study showed that PDT 
induces  apoptosis  and  ROS  generation  in  HUVEC  cells.  Moreover,  these  biochemical  events  
are  effectively  blocked  upon  pretreatment  with  L-histidine,  a  singlet  oxygen-specific  scavenger 
(Figure 1A, B), confirming that PDT triggers apoptosis of HUVECs via singlet oxygen generation. 
Figure 1. Photodynamic treatment (PDT) induces apoptosis and reactive oxygen species 
(ROS) generation of HUVECs. HUVECs  were incubated with or without Rose Bengal  
(5 μM; RB) and/or L-histidine (500 μM; H) in the dark at 37 ° C for 1 h. Cells were treated 
with visible light (L) for 30 min or left untreated, followed by incubation in the absence of 
light at 37 ° C for a further 12 h. (A) Apoptosis was detected with the Cell Death Detection 
ELISA kit; (B) ROS generation was assayed using  DCF-DA (20 μM) dye. Values are 
presented  as  means  ±   SEM  of  six  determinations.  *** P < 0.001  versus  the  untreated 
control group (CON); 
# P < 0.001 versus the PDT-treated group. 
    
 
Changes in [Ca
2+]i in HUVECs subjected to PDT were detected using the Fluo-3AM fluorescence 
dye. Cells cultured in Ca
2+-containing medium showed a ~2.2-fold increase in [Ca
2+]i following PDT, 
whereas this increase had no effect in treated cells cultured in Ca
2+-free medium (Figure 2A). These 
findings indicate that the rise in [Ca
2+]i is primarily attributed to calcium release from intracellular 
stores, such as those found in the endoplasmic reticulum, mitochondria, nucleus and/or calcium-binding 
proteins (Figure 2A). In addition, L-NMMA, an inhibitor of NOS, and PTIO, an inhibitor of NOS and 
scavenger  of  NO,  had  no  effect  on  the  PDT-induced  [Ca
2+]i  increase,  whereas  pretreatment  with  
L-histidine led to a significant decrease in [Ca
2+]i (Figure 2A). The results suggest that elevation of 
[Ca
2+]i induced by PDT is regulated by singlet oxygen generation, but not NO. Experiments using the 
NO-sensitive dye, DAF-2DA, to measure intracellular NO generation during PDT-induced apoptosis 
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revealed  increased  NO  levels  in  HUVECs  (Figure  2B).  However,  this  increase  was  prevented  by 
pretreatment of cells with the NOS inhibitor, L-NMMA, or the Ca
2+ chelator, EGTA (Figure 2B). 
Real-time RT-PCR analyses disclosed significant upregulation of endothelial cell nitric oxide synthase 
(eNOS)  in  HUVECs  exposed  to  PDT,  which  was  effectively  blocked  upon  pretreatment  with  
L-histidine or PTIO (Figure 2C). These results suggest that intracellular Ca
2+ levels play an important 
role in NOS activation and NO increase observed in HUVECs subjected to PDT.  
Figure 2. PDT triggers changes in the intracellular calcium and nitric oxide (NO) content 
in  HUVECs.  HUVECs  were  incubated  with  or  without  Rose  Bengal  (5  μM;  RB),  
L-histidine (500 μM; H), L-NMMA (400 μM), PTIO (20 μM), and EGTA (500 μM) in the 
dark at 37 ° C for 1 h. Cells were treated with visible light for 30 min or left untreated, and 
incubated in the absence of light at 37 ° C for a further 12 h. (A) Intracellular Ca
2+ level 
changes  were  measured  via  estimation  of  intracellular  Fluo-3  fluorescence  intensity;  
(B)  Intracellular  NO  generation  was  measured  using  the  DAF-2DA  fluorescence  dye;  
(C)  The mRNA levels  of endothelial  cell nitric oxide synthase (eNOS) were analyzed  
using real-time PCR. Data are presented as percentage or fold, compared to the control  
group (CON). *** P < 0.001 versus the untreated control  group; 
# P < 0.001 versus the  
PDT-treated group. 
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Mitochondrial membrane potential (MMP) changes are directly associated with apoptosis [36–38], 
and MMP changes observed in PDT-exposed cells [39]. Examination of the effects of PDT on MMP 
changes  in  HUVECs  revealed  suppression  of  uptake  of  DiOC6(3)  and  TMRE  into  mitochondria, 
indicative of significant MMP loss (Figure 3A). We additionally monitored activation of caspases-9 
and -3, which are involved in MMP change-mediated apoptosis. Photodynamic treatment of HUVECs 
stimulated the activities of both caspases-9 (Figure 3B) and -3 (Figure 3C). Notably, both MMP loss 
and caspase activation were significantly inhibited upon incubation of cells with 20 μM PTIO prior to 
PDT (Figure 3A–C). Our results indicate that NO acts as an upstream regulator for loss of MMP and 
activation of caspases-9 and -3 during PDT-induced apoptosis of HUVECs.  
Figure 3. PDT induces mitochondrial membrane potential (MMP) changes and caspase 
activation in HUVECs. HUVECs were pre-treated with or without PTIO (20 μM) for 1 h 
and exposed to PDT or left untreated. (A) To examine MMP changes, cells were incubated 
with  40  nM  DiOC6(3)  or  1  μM  TMRE  at  37  °C  for  1  h,  and  analyzed  using 
spectrofluorometry; (B) Caspase-9 activity was assayed using the Colorimetric Caspase-9 
Assay  kit;  (C)  Caspase-3  activity  was  analyzed  using  Z-DEVD-AFC  as  the  substrate. 
Values are presented as means ±  SEM of eight determinations. *** P < 0.001 versus the 
untreated control group (CON); 
# P < 0.001 versus the PDT-treated group. 
 
    
 
 
 
In view of previous findings that p21-activated protein kinase 2 (PAK2) and JNK are activated 
during  apoptosis  and  subsequently  involved  in  apoptotic  signaling  events  in  PDT-exposed 
A431 [9,27,28], we investigated the involvement of PAK2 and JNK in PDT-triggered apoptosis of 
HUVECs.  Immunoprecipitation  kinase  activity  assays  revealed  PAK2  and  JNK  activation  in  
PDT-exposed HUVECs, which were effectively prevented by pre-treatment with PTIO (Figure 4A, B). 
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To further establish the relationship between PAK2 and JNK activation as well as the specific function 
of PAK2 in PDT-induced apoptosis, we incubated HUVECs with anti-sense or sense oligonucleotides 
against  PAK2  for  three  days,  subjected  the  cells  to  PDT,  and  analyzed  PAK2  activity  via 
immunoprecipitation. Pre-incubation of HUVECs with an anti-sense oligonucleotide against PAK2 led 
to a significant decrease in the PAK2 level (by ~40%), compared to control cells exposed to PDT, 
whereas the sense oligonucleotide had no such effect (Figure 4C). This decreased PAK2 activation was 
associated with significant decreases in PDT-induced activation of JNK and apoptosis (Figure 4D, E). 
Thus, our findings strongly suggest that PAK2 plays an important role in PDT-induced JNK activation 
and apoptosis of HUVECs.  
Figure  4.  PAK2  and  JNK  are  activated  during  PDT-induced  apoptosis  of  HUVECs. 
HUVECs were pre-treated with or without PTIO (20 μM) for 1 h, followed by PDT. After 
treatment, cells were further incubated in the absence of light at 37 ° C in a CO2 incubator 
for 12 h. (A) PAK2 was immunoprecipitated and kinase activities assayed using myelin 
basic  protein  as  the  substrate;  (B)  Cell  extracts  (60  μg)  were  analyzed  for  JNK/AP-1 
activity with the ELISA kit; (C–E) Cells were transfected with buffer (Bu), sense (S) or 
anti-sense (AS) oligonucleotides for 72 h, and subjected to PDT. PAK2 activity (C), JNK 
activity  (D),  and  cell  apoptosis  (E)  were  assessed.  *** P < 0.001  versus  the  untreated 
control group (CON); 
# P < 0.001 versus the PDT-treated group. 
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Figure 4. Cont. 
 
Real-time RT-PCR analyses disclosed significant upregulation of p53 and p21 mRNA levels in 
HUVECs subjected to PDT. Moreover, these changes were blocked upon pretreatment with L-histidine 
or PTIO (Figure 5A, B). To further ascertain the roles of p53 and p21 in PDT-induced apoptosis, we 
used targeted siRNAs to suppress p53 expression in HUVECs, followed by photodynamic treatment of 
cells and testing for viability. The p53 siRNA-mediated knockdown led to a significant decrease in p53 
and p21 mRNA expression in PDT-exposed HUVECs (Figure 6A). These decreases in p53 and p21 
mRNA were associated with a significant reduction in PDT-induced activation of PAK2 (Figure 6B) 
and apoptosis (Figure 6C). Based on these findings, we suggest that PDT upregulates p53 and p21 
expression levels in HUVECs, which contribute to subsequent apoptosis of treated cells. 
Figure 5. Effects of L-histidine and PTIO on the mRNA expression levels of p53 and p21. 
HUVECs were pre-incubated with or without L-histidine (500 μM; H) and PTIO (20 μM) 
for 1 h, followed by PDT. The mRNA levels of p53 (A) and p21 (B) were analyzed using 
real-time PCR. The given values are representative of five independent determinations. 
*** P < 0.001  versus  the  untreated  control  group  (CON); 
# P < 0.001  versus  the  
PDT-treated group. 
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Figure 6. Knockdown of p53 protects HUVECs against PDT-induced apoptosis. HUVECs 
were transfected with siRNA targeting p53, incubated for 24 h, and subjected to PDT. 
(A) The  p53  and  p21  mRNA  levels  were  analyzed  using  real-time  PCR;  (B)  PAK2 
activities were assayed using myelin basic protein as the substrate; (C) Cell apoptosis was 
measured  as  described  in  Figure  1.  *** P < 0.001  versus  the  untreated  control  group; 
# P < 0.001 versus the PDT-treated group. 
 
    
 
 
 
A recent study by our group further showed that additional regulatory mechanisms are involved in 
PDT-induced apoptosis in HUVECs. Caraglia et al. reported that survival signaling processes protect 
against apoptosis induced by specific stimuli [40,41]. Furthermore, some apoptotic stimuli inhibit the 
Ras→ERK  survival  signal  pathway  by  suppressing  the  protein  levels  of  various  survival 
components [41–43]. Experiments from the current study disclosed that PDT triggers a decrease in the 
HSP90 and Ras protein levels and inhibits ERK activity (Figure 7A). Inhibition of protein expression 
and activities of survival signal components by PDT was effectively blocked upon pretreatment with 
lactacystin, a specific proteasome inhibitor (Figure 7A). Moreover, lactacystin prevented PDT-induced 
apoptosis in correlation with blockage of the decrease in survival signal components (Figure 7A, B). 
Our data suggest that Ras proteins are degraded via proteasome-dependent pathways in PDT-treated 
HUVECs, subsequently leading to reduction of ERK activity for apoptosis. 
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Figure 7. Effect of PDT on HSP90 and components of survival signaling. HUVECs were 
incubated  with  or  without  lactacystin  (LC;  10  μM)  for  1  h,  and  subjected  to  PDT.  
(A) The protein levels of HSP 90, Ras and ERK-1/2, and phosphorylation of ERK-1/2 were 
evaluated. β-actin was used as the loading control; (B) Cell apoptosis was detected with the 
TUNEL  assay.  Data  are  representative  of  five  independent  experiments.  *** P < 0.001 
versus untreated control group (CON); 
# P < 0.001 versus PDT-treated group. 
 
      
 
In recent years, PDT has emerged as a promising therapeutic protocol for treatment of malignant 
and non-malignant diseases [5]. Previous studies by our group have shown that PDT elicits singlet 
oxygen  formation  in  A431  cells,  and  singlet  oxygen  scavengers  prevent  PDT-induced  caspase-3 
cleavage/activation  and  subsequent  PAK2  activation  [9,10].  In  addition,  PDT  has  been  shown  to 
induce cancer cell apoptosis via the Ca
2+ and NO-mediated signal pathway [14]. In the present study, 
we have further clarified the regulatory roles of singlet oxygen, NO, calcium, p53, PAK2 and JNK in 
PDT-induced apoptosis of HUVECs. 
Intracellular calcium levels play an important role in regulating cell death [14,44,45]. In the present 
study,  we  examined  whether  PDT  induces  apoptosis  of  HUVECs  through  intracellular  calcium 
increase. We observed increases in [Ca
2+]i following PDT, which were largely attributed to influx of 
Ca
2+ from intracellular Ca
2+ storage organelles (Figure 2). This effect was significantly blocked by  
L-histidine (Figure 2), indicating that PDT-induced singlet oxygen generation is responsible for the 
elevation of intracellular calcium concentrations in PDT-treated HUVECs.  
NO is an endogenous product generated from the catalysis of NADPH, O2 and L-arginine by nitric 
oxide synthase. A recent study demonstrated that NO is involved in apoptosis triggered by several 
different  types  of  stimuli  [14,15].  The  regulatory  actions  of  NO  on  the  mitochondrial  apoptotic 
signaling pathways are well documented. Decreased ratios of Bcl-2/Bax and inhibition of electron 
transport are among the regulatory mechanisms of NO-mediated apoptosis [46]. Decreased Bcl-2/Bax 
ratio and impairment of mitochondrial electron transport may  trigger loss of MMP and release of 
cytochrome  c,  which  are  involved  in  the  control  of  apoptosis.  In  addition,  tamoxifen  treatment 
increases intramitochondrial Ca
2+ concentrations, leading to stimulation of mitochondrial NO synthase 
activity and NO production in rat livers and human breast cancer MCF-7 cells [15]. Here, we observed 
NO generation following PDT of HUVECs, with ~3.2-fold higher intracellular NO levels in treated 
cells  versus  untreated  controls  (Figure  2B).  Pretreatment  with  EGTA  significantly  prevented  this 
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increase in intracellular NO (Figure 2B), implying that NO production in PDT-treated HUVECs is 
dependent on the intracellular calcium concentration. Furthermore, consistent with the  finding that 
NOS is the main source of NO during stimulus-triggered apoptosis [14,15], we observed ~2.5-fold 
higher eNOS mRNA in PDT-treated HUVECs versus untreated controls (Figure 2C). The regulatory 
role of NO in apoptosis is complex, and NO-mediated apoptotic effects are modulated via distinct 
mechanisms  in  different  cell  types  [13,47].  NOS  substrates  and  NO  donors  inhibit  photodynamic 
treatment-induced apoptosis in CCRF-CEM cells [48]. In the current study, PTIO treatment attenuated 
MMP  loss  and  decreased  caspase  activation  (Figure  3A–C),  suggesting  that  NO  generation  is  an 
important mediator of apoptosis in PDT-exposed HUVECs. 
Recently, our laboratory and other researchers showed that PAK2 is a target substrate for caspases 
activated by various apoptotic stimuli, including anti-Fas antibodies, tumor necrosis factor-α, ceramide 
and environmental stress factors, such as UV irradiation, heat shock and hyperosmotic shock [26–28,49]. 
Activation of PAK2 appears to be a critical step for stimulation of JNK activity during PDT-induced 
apoptosis  [9,10].  However,  the  functional  role  of  caspase-generated  activation  of  PAK2  remains 
obscure  at  present.  In  previous  experiments,  apoptosis  was  delayed  upon  transfection  of  
dominant-negative PAK2 (full-length or N-terminally truncated) into CHO cells stably expressing a 
CD4-Fas  chimera  [26].  Similarly,  microinjection  of  active  PAK  into  early  frog  embryos  caused 
cleavage arrest [50,51]. Recent studies further demonstrated that an anti-activated PAK2 polyclonal 
antibody recognizes  several  phosphoproteins  in mitotic HeLa and A431 cells,  including lamins  A 
and C  [52].  PAKs  are  significantly  involved  in  cell  cycle  control.  Our  group  recently  showed  an 
association  of  decreased  PAK2  protein  expression  and  activation  with  significant  inhibition  of 
methylglyoxal-induced apoptosis in human osteoblasts [53], strongly suggesting that PAK2 plays an 
important role in apoptosis triggered by methylglyoxal. Data from the current study demonstrate that 
PAK2 is an important upstream regulator of JNK activation in PDT-directed apoptosis of HUVECs 
(Figure 4). JNK plays critical roles in apoptosis [23,24]. Based on the results, we propose that PDT 
triggers singlet oxygen generation and caspase-3 activation, in turn, inducing PAK2 and sequential 
activation of JNK, and ultimately, apoptosis. 
NO-mediated apoptotic processes are associated with p53 gene activation, which is essential for 
regulation of the cell cycle and/or apoptotic signaling occurring through p21
Waf1/Cip1 or Bax [54,55]. In 
our current study, p53 and p21 mRNA levels were upregulated upon treatment with PDT, and these 
increases were blocked upon pretreatment with PTIO (Figure 5A,B). Furthermore, siRNA-mediated 
knockdown of p53 mRNA expression prevented the PDT-induced increase in p21 mRNA and PAK2 
activation, and led to a decrease in subsequent apoptosis (Figure 6A–C). These results indicate that 
genes encoding p53 and p21 are activated during PDT-induced apoptosis of HUVECs.  
Heat  shock  proteins  (HSP)  protect  proteins  against  proteasome-  and  ubiquitin-dependent 
degradation  [56,57].  HSP90,  the  most  abundant  molecular  chaperone  protein  in  the  intracellular 
system, is involved in maintaining the correct conformations of intracellular proteins and kinases, such 
as Raf-1 [58,59], which regulates cell proliferation and survival. Data from the present study showed 
an association between PDT-induced apoptosis and reduced expression of survival components, such 
as Ras. Inactivation of ERK-1 and ERK-2 and pretreatment with lactacystin, a proteasome inhibitor, 
prevented the PDT-mediated decrease in protein expression or activity (Figure 7A). Moreover, PDT 
suppressed  HSP90  expression,  thus  promoting  the  degradation  of  client  proteins  (Figure  7A). Int. J. Mol. Sci. 2011, 12                       
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Accordingly, we hypothesize that the PDT-induced reduction of HSP90 stimulates Ras targeting for 
degradation, leading to its downregulation and changes in the related signal pathways. 
Importantly, previous studies have shown that PDT triggers cell apoptosis through the Ca
2+ and 
NO-mediated signal pathway. Moreover, our group has demonstrated that singlet oxygen-mediated 
JNK activation is required for caspase and PAK2 activities that further elicit second-stage activation of 
JNK to trigger PDT-induced apoptosis [9,14]. The present report reveals for the first time that PDT 
triggers apoptosis through Ca
2+ influx and NO production to affect P53 protein expression, and causes 
sequent  apoptotic biochemical  changes,  including loss of MMP as  well as  activation of  caspases, 
PAK2  and  JNK in  HUVEC  cells.  Furthermore,  we  did  not  observe  two-stage  JNK  activation  for 
regulation of PAK2 activity in the PDT-induced apoptotic pathway in HUVECs, which was reported 
earlier in A431 cells [9]. The results clearly indicate that PDT induces apoptosis through different 
mechanisms, depending on cell type. 
3. Experimental Section 
3.1. Chemicals 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium  bromide  (MTT),  2-phenyl-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (PTIO), L-histidine, 2’,7’- dichlorofluorescein diacetate (DCF-DA) 
and goat anti-rabbit immunoglobulin G (IgG) antibodies conjugated with alkaline phosphatase were 
purchased from Sigma (St. Louis, MO, U.S.). Anti-p53, anti-p21, anti-JNK1 (C17), anti-p-JNK (G-7) 
and anti-β-actin antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.). Z-DEVD-
AFC  was  obtained  from  Calbiochem  (La  Jolla,  CA,  U.S.).  The  CDP-Star
TM  chemiluminescent 
substrate for alkaline phosphatase was acquired from Boehringer Mannheim (Mannheim, Germany). 
3.2. Cell Culture and PDT  
Human umbilical vein endothelial cell (HUVEC) strain (ECV-304) was obtained from the ATCC, 
and the cells were cultured at 37 ° C in a CO2 incubator in M199 medium containing 10% fetal calf 
serum, with medium changes every 24 h. For PDT, cells were incubated in medium containing 5 μM 
Rose Bengal  (RB) in the dark for 30 min at 37 ° C, followed by irradiation with a commercially 
available 120 W lamp from a fixed distance of 30 cm for 30 min. Cells were incubated in the absence 
of light at 37 ° C in a CO2 incubator for another 12 h. The spectral output of the light source and 
fluence rate at the surface of cultures in the visible light region were as reported previously by our 
group [9]. PDT treatment conditions were similar for all the experiments performed in this study. 
During all treatment periods, cells were incubated with medium containing 5 μM RB. Cells were then 
washed twice with ice-cold PBS and lysed on ice for 10 min in 400 μL lysis buffer (20 mM Tris-HCl 
at  pH  7.4,  1  mM  EDTA,  1  mM  EGTA,  1%  Triton  X-100,  1  mM  benzamidine,  1  mM 
phenylmethylsulfonyl  fluoride,  50  mM  NaF,  20  μM  sodium  pyrophosphate  and  1  mM  sodium 
orthovanadate). Cell lysates were sonicated on ice for 3 ×  10 s, then centrifuged at 15,000 ×  g for 
20 min at 4 ° C, and the supernatants used as cell extracts. Int. J. Mol. Sci. 2011, 12                       
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3.3. Apoptosis Assay 
Oligonucleosomal  DNA  fragmentation  in  apoptotic  cells  was  measured  using  the  Cell  Death 
Detection ELISA
plus kit according to the manufacturer’s protocol (Roche Molecular Biochemicals). 
Cells (1 ×  10
5) were treated with or without PDT for 30 min at 37 ° C. Spectrophotometric data were 
obtained using an ELISA reader at a wavelength of 405 nm. 
3.4. ROS Assay 
ROS  were measured in arbitrary units  using 2’,7’-dichlorofluorescein  diacetate (DCF-DA) dye. 
Cells (1.0 ×  10
6) were incubated in 50 μL PBS containing 20 μM DCF-DA for 1 h at 37 ° C, and 
subsequently exposed to PDT. Cells were further incubated in the absence of light at 37 ° C in a CO2 
incubator  for  12  h,  and  the  relative  ROS  units  determined  using  a  fluorescence  ELISA  reader 
(excitation  485  nm,  emission  530  nm).  An  aliquot  of  the  cell  suspension  was  lysed,  the  protein 
concentration was determined, and the results were expressed as arbitrary absorbance units/mg protein. 
3.5. Detection of Intracellular Calcium Concentration ([Ca
2+]i) 
The [Ca
2+]i was detected with Fluo-3 AM fluorescence dye, using a modification of the previously 
reported method [14,60]. Briefly, HUVECs were PDT treated, harvested and washed, and then loaded 
with  6 μM  Fluo-3  AM in  standard  medium  (140  mM  NaCl,  5  mM  KCl,  1 mM  MgCl2,  5.6 mM 
glucose, 1.5 mM CaCl2, and 20 mM Hepes, pH of 7.4). After 30 min, the cells were washed 3 times 
with PBS and then resuspended in standard medium or Ca
2+-free standard medium. The fluorescence 
intensity  of  Fluo-3  was  determined  using  a  fluorescence  spectrophotometer  (Hitachi,  F-2000; 
excitation at 490 nm, emission at 526 nm).  
3.6. Detection of Intracellular NO Content 
The DAF-2DA fluorescence dye was used to detect intracellular NO, according to a modification of 
the previously reported method [14,61]. Briefly, treated or control cells were collected and washed, 
and then incubated with 3 μM DAF-2DA. After 60 min, the cells were washed 3 times with PBS and 
the  fluorescence  intensity  was  measured  by  a  fluorescence  spectrophotometer  (Hitachi,  F-2000; 
excitation at 485 nm, emission at 515 nm). 
3.7. Detection of Mitochondrial Membrane Potential (MMP) 
HUVECs were plated and grown on 96-well plates for 24 h, and then treated by PDT. The cells 
were then separately exposed to the fluorescent dyes, DiOC6(3) (40 nM/well) or TMRE (1 μM/well), 
for  15  min,  and  fluorescence  was  measured  with  a  plate  spectrofluorometer  (excitation:  485  nm 
(DiOC6(3)), 535 nm (TMRE); Emission: 535 nm (DiOC6(3)), 590 nm (TMRE)). Int. J. Mol. Sci. 2011, 12                       
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3.8. Caspase Activity Assays 
Caspase-9  activity  was  assayed  using  the  Colorimetric  Caspase-9  Assay  Kit  (Calbiochem,  CA, 
U.S.). Caspase-3 activity was measured using the Z-DEVD-AFC fluorogenic substrate, as previously 
described [62,63].  
3.9. Immunoprecipitation and PAK2 Activity Assay 
The PAK2  antibody  was  prepared in our laboratory  as  described previously  [64].  In brief, the  
anti-PAK2 (C15) antibody was produced in rabbits using the antigen peptide, TPLIMAAKEAMKSNR, 
which corresponds to C-terminal residues 510–524 of the human and rabbit PAK2 sequences [65,66]. 
A cysteine residue was added to the N-terminus to facilitate coupling of the peptide to keyhole limpet 
hemocyanin, as previously described [67]. Glutaraldehyde was used as the cross-linker. The anti-peptide 
antibody was produced and affinity purified as previously described [64]. Before immunoprecipitation, 
cell extracts were diluted to equal protein concentrations (1.0 mg/mL) with cell lysis solution. For 
immunoprecipitation  of  the  C-terminal  catalytic  fragment  of  PAK2,  0.5  mL  of  cell  extract  was 
incubated with 10 μL of anti-PAK2 (C15) antibody (200 μg/mL) at 4 ° C for 1.5 h, and then further 
incubated  with  40  μL  of  Protein  A-Sepharose  CL-4B  (30%,  v/v)  for  1.5  h  with  shaking.  The 
immunoprecipitates were collected by centrifugation, washed three times with 1 mL of Solution A 
(20 mM Tris/HCl, pH 7.0, and 0.5 mM DTT) containing 0.5 M NaCl, and resuspended in 40 μL of 
Solution A. For measurement of PAK2 activity, the immunoprecipitates were incubated in a 50 μL 
mixture containing 20 mM Tris/HCl, pH 7.0, 0.5 mM DTT, 0.2 mM [γ-p
32]ATP, 20 mM MgCl2 and 
0.1  mg/mL  myelin  basic  protein  (MBP)  at  room  temperature  for  10  min  with  shaking.  For 
determination of 
32P incorporation into the MBP protein, 20 μL of each reaction mixture was spotted 
onto Whatman P81 paper (1 ×  2 cm), which was then washed with  75 mM phosphoric acid and 
processing as previously described [68]. 
3.10. JNK Assays 
JNK activity, as assayed by the presence of phosphorylated c-Jun protein, was analyzed with the 
AP-1/c-Jun ELISA kit, according to the manufacturer’s protocol (Active Motif, Carlsbad, CA, U.S.). 
Briefly, AP-1 heterodimeric complexes were collected from cellular nuclear extracts by binding to a 
consensus 5’-TGA(C/G)TCA-3’ oligonucleotide coated on a 96-well plate. The phospho-c-Jun was 
assayed using a phospho-c-Jun primary antibody and a secondary horseradish peroxidase-conjugated 
antibody in a colorimetric reaction. 
3.11. Inhibition of PAK2 by Anti-sense Oligonucleotides 
PAK2 sense (5’-ATC ATG TCT GAT AAC GGA GAA) and anti-sense (5’-TTC TCC GTT ATC 
AGA CAT GAT) oligonucleotides, representing amino acids −1 to +7 of human PAK2, were obtained 
from  Life  Technologies  (Grand  Island,  NY).  The  oligonucleotides  were  synthesized  under 
phosphorothioate-modified conditions, purified by HPLC, and dissolved in 30 mM HEPES buffer, 
pH 7.0. For transfections, cells grown in 60 mm culture dishes were incubated at 37 ° C in 1 mL of  
Opti-MEM I medium (modified Eagle’s minimum essential medium buffered with HEPES and sodium Int. J. Mol. Sci. 2011, 12                       
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bicarbonate), containing lipofectAMINE4 (12 μg) and oligonucleotides (70 μM) for 72 h (all reagents 
from Life Technologies, Grand Island, NY, U.S.). The cells were then subjected to PDT, and the cell 
extracts were analyzed as described above. 
3.12. Real-Time RT-PCR Assay 
Total RNA was extracted with the TRIzol reagent (Life Technologies) and purified with an RNeasy 
Mini kit (Qiagen), according to the manufacturers’ protocols. Real-time PCR was carried out with an 
ABI 7000 Prism Sequence Detection System (Applied Biosystems). The β-actin mRNA levels were 
quantified as an endogenous control, and used for normalization. The primers used for PCR were as 
follows: eNOS, 5′-CCT TTG CTC GTG CCG TGG AC-3′ and 5′-GCC CTC GTG GAC TTG CTG 
CTT-3′; p53, 5′-CCC ATC CTC ACC ATC ATC AC-3′ and 5′-GTC AGT GGG GAA CAA GAA 
GTG-3′; p21, 5′-GCC GAA GTC AGT TCC TTG TGG A-3′ and 5′-GTG GGC GGA TTA GGG CTT-3′. 
3.13. siRNA Knockdown 
Lipofectamine  was  used  to  transfect  HUVECs  with  150  nM  of  siRNA  for  targeting  against  
p53  (5'-GACUCCAGUGGUAAUCUACTT-3';  sip53),  or  a  scrambled  control  duplex  
(5′-GCGCGCUUUGUAGGAUUCG-3′;  siScr).  Twenty-four  hours  post-transfection,  fresh  culture 
medium was added, and the cells were treated by PDT.  
3.14. Immunoblots 
Immunoblotting was performed essentially as described in a previous report by our group [69]. 
Briefly, proteins were resolved by SDS-PAGE, transferred to PVDF membranes, and immunoblotted 
with anti-HSP 90, anti-Ras, anti-phospho ERK1/2 and anti-ERK1/2 antibodies (0.25 μg/mL). Proteins 
of  interest  were  detected  with  secondary  alkaline  phosphatase-conjugated  goat  anti-rabbit  or  
anti-mouse  IgG  antibodies,  and  visualized  using  the  CDP-Star
TM  chemiluminescent  substrate, 
according to the manufacturer’s protocol. 
3.15. Statistics 
Data were analyzed using one-way ANOVA, and differences were evaluated using a two tailed 
Student’s t-test and analysis of variance. P < 0.05 was considered significant. 
4. Conclusions  
Based on the present findings, we have proposed a model of the PDT-induced apoptotic signaling 
pathways in HUVEC cells (Figure 8). 
 Int. J. Mol. Sci. 2011, 12                       
 
 
1055 
Figure 8. Scheme of events occurring during PDT-induced HUVEC cell death. 
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